Page 1455 - Problem-Based Feline Medicine

1448 INDEX

Lens (Continued) Lipemia retinalis, 572, 1166, 1185–1186 Liver tumors, non-hematopoietic, 422,
rupture, ulcerative keratitis, Lipemic aqueous, 1255, 1270 436–437
1243 Lipiduria, 206, 214–215 Lizards envenomation, 285
structure, 1258–1259 Lipoprotein Lobaplatin, 1380
trauma, cataract formation, 1257, quantification of, 573 Lockjaw, 1339
1272–1273 structure, 571 Locus ceruleus (LC), 999, 1011
Lens fibers (cells), 1258 types of, 570–571 Lomustine, 461
Lens-induced uveitis, 1257, 1274 Lipoprotein lipase, 571 Loperamide, 1380
Lente, diabetes mellitus, 238, 313 activity absence, 575 Loratidine, 23
Lentectomy, 1273 quantification of activity, 573 Louse, Felicola subrostratus, 1036
Lentigo simplex (hyperpigmentation), Lisiopril, 1380 Low-density lipoproteins (LDL), 571,
1108, 1113 Lissencephaly-pachygyria, 805 572
Leprosy, 407–408, 1083, 1090 Litter box Low-dose dexamethasone suppression
Leptospirosis, 446, 478 accessibility, 221 (LDDS), 1064
Lesions, hemorrhage, 482, 492–493 aversion, 1011, 1012 Lower airway infections, 604, 609
Lethargy, thiamine deficiency, 848 dissatisfaction, 782, 789–790 Lower airway obstructions, 51
Leucovorin, 1379 location, 1011–1012, 1013 Lower motor neuron (LMN)
Leukocyte activation, 367–368 number of, 1013 paraparesis, 912–913
Leukotriene(s), asthma, 93 substrate aversion, 1012 Lower motor neuron (LMN)
Leukotriene receptor blockers, 95 substrate preference, 1012, 1013 paraplegia, 915
Levallorphan, 1379 Litters, large, 1135 Lower motor neuron (LMN) paresis,
Levamisole, 1379 Liver see below; entries beginning 908
Levarterenol, 1379 hepatic Lower respiratory tract signs, 47–123
Levetiracetam, 1379 Liver biopsy coughing, 90–108
Levodopa, 1379 cirrhosis, 435–436 cyanosis, 109–123
Levothyroxine, 1379, 1400 feline cholangitis, 429 dyspneic/tachypneic, 47–70
L-form infection(s) hepatopathies, 639 hydrothorax, 71–89
cellulitis, 368 lymphocytic cholangiohepatitis, 321 see also specific diseases/disorders
lymphadenopathy, 417 Liver disease, 498–499 Lower urinary tract disease (LUTD),
lymph nodes, enlarged, 395 clinical signs, 498, 509 790–791
non-healing wound, 1087, 1088 coagulopathy, 473 clinical signs, 790
Lidocaine, 165, 1379 diagnosis, 275, 498 constipation/straining, 782, 790–791
Lignocaine, 972, 1343, 1348 differential diagnosis, 499 diagnosis, 790
Lilium poisoning, 290–291 hemorrhage, 484, 498–499 differential diagnosis, 790
Lily poisoning, 265, 276, 288, metabolic epidermal necrosis and, hematuria from, 206, 208–209
290–291 1099 non-obstructed, 174, 222,
Limbic system, obsessive-compulsive pathogenesis, 498 790–791
disorder, 1011 prognosis, 499 non-obstructed idiopathic, 176–179,
Limb paralysis/paresis, 58 treatment, 499 218
Lime-sulfur dips, 1380 see also specific diseases/disorders clinical signs, 177, 188
cat fur mite (Lynxacarus radovsky), Liver enzymes diagnosis, 177
1041 elevated, 421–442 differential diagnosis, 177
demodicosis, 1048 causes/disease causing, 421–423, pathogenesis, 176–177
Notoedres cati (notoedric mange), 424 prognosis, 178–179
1040 location, 421, 424 straining to urinate, 176–179
parasitic pododermatitis, 1112 mechanism, 421, 424 treatment, 178
Lime water, 1380 ruptured bile duct, 441 obstructed, 174, 790, 791
Limping kitten syndrome, 11, 583 Liver feeding, hypovitaminosis A, neoplasia causing, 444, 474
Linalool toxicity, 580, 598–599 1159 obstructed idiopathic, 179–184
Lincomycin, 1380 Liver flukes (Amphimerus clinical signs, 179–180
Lindane, Otodectes cynotis, 1038 pseudofelineus), 273 diagnosis, 180
Liothyronine, 1380 Liver function studies, metabolic differential diagnosis, 180
Lipemia, 570 encephalopathy, 831 pathogenesis, 179